Pathways Picks December 2: Angst and Advancement in Europe, Medicare Machinations, and More

article image

This week’s roundup is chock-full of updates and insights in two areas: EU regulations and US Medicare policy. There have been some important policy advancements in both spheres over the past week, but also continuing controversies.

With about five months to the MDR and 18 months to the IVDR, pressure is building in the EU. There were some points of progress for implementation of these new regulations in the past week, but also signs of potential setbacks. Those developments lead this week’s Pathways’ Picks, followed by US CMS updates and more on medtech policy from around the globe  

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: